Trial · NCT02264613
Adverse events952
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 952
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (0.16 mg/kg) | 1 | 5 | 1 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (0.32 mg/kg) | 1 | 3 | 1 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (0.64 mg/kg) | 2 | 4 | 2 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (1.25 mg/kg) | 3 | 3 | 3 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (2.1 mg/kg) | 5 | 6 | 5 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (3.1 mg/kg) | 9 | 9 | 9 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (4.4 mg/kg) | 6 | 11 | 6 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen B (DR-B) Escalation (0.32 mg/kg) | 3 | 3 | 3 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen B (DR-B) Escalation (0.53 mg/kg) | 4 | 5 | 4 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen B (DR-B) Escalation (0.8 mg/kg) | 3 | 3 | 3 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen B (DR-B) Escalation (1.1 mg/kg) | 3 | 4 | 3 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen B (DR-B) Escalation (1.5 mg/kg) | 4 | 4 | 4 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen B (DR-B) Escalation (2.0 mg/kg) | 5 | 5 | 5 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen B (DR-B) Escalation (2.7 mg/kg) | 3 | 6 | 3 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen A (DR-A) PTCL Expansion | 10 | 21 | 10 |
| other | Nausea | Gastrointestinal disorders | Dose Regimen C (DR-C) PTCL Expansion | 7 | 16 | 7 |
| other | Nausea | Gastrointestinal disorders | Combination With Palbociclib Expansion | 19 | 34 | 19 |
| other | Vomitting | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (0.16 mg/kg) | 0 | 5 | 0 |
| other | Vomitting | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (0.32 mg/kg) | 1 | 3 | 1 |
| other | Vomitting | Gastrointestinal disorders | Dose Regimen A (DR-A) Escalation (0.64 mg/kg) | 1 | 4 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02264613/events